Stock Expert AI
Equity research screen

AbbVie (ABBV) vs. Merck (MRK) Stock Comparison and Analysis

This page provides a comparative overview of AbbVie Inc. (ABBV) and Merck & Co. (MRK). It delivers an objective snapshot of each company, useful for investors seeking to understand the relative strengths of these two major pharmaceutical stocks. The analysis does not provide financial advice but offers data points for consideration.

Quick Answer This page analyzes AbbVie (ABBV) and Merck (MRK), two major pharmaceutical stocks. It presents a data-driven comparison of their valuation and market capitalization. The analysis is based on current financial metrics. Investors may use this objective overview to inform their understanding of the relative strengths of each company. Note that this is not financial advice.
Screens40Average score78.00Updated2026-04-10Prices as ofOct 26, 2026 session

Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures.

MoonshotScore V2 rates eligible US-listed companies from 0 to 100 against their sector peers on five pillars: Business Quality (weight 26), Financial Safety (weight 20), Valuation (weight 18), Growth Durability (weight 16) and Momentum (weight 12). It reads no news-sentiment or analyst data, and it is not a probability of future returns.

20,000+ US companies analyzed

AbbVie vs. Merck: Key Considerations

When evaluating pharmaceutical stocks such as AbbVie (ABBV) and Merck (MRK), investors often consider factors like current valuation, cash flow generation, and growth prospects. This comparison offers a concise look at these aspects, helping to frame an investment decision within the context of each company's profile and market capitalization.

ABBV vs MRK: The Numbers

Side by side on the figures we publish for both companies. Not a ranking and not a recommendation — the same metrics, read off the same source, on the same day.

ABBV and MRK on five published metrics — MoonshotScore and P/E from our latest stored data; prices, day change and market cap as of the Oct 26, 2026 trading session (FMP quote). Source: Financial Modeling Prep, Yahoo Finance.
Metric ABBVAbbVie Inc.MRKMerck & Co.
MoonshotScore 8076
Price $286.79$140.61
Change (1D) +0.40%-3.21%
Market cap $506.8B$346.9B
P/E ratio ——

A dash means we hold no published figure for that company — not a zero. Full analysis: ABBV · MRK.

AbbVie (ABBV) and Merck (MRK): A Concise Comparison

This section offers a summary of key data points: * AbbVie (ABBV): Review AbbVie's stock information. * Merck & Co. (MRK): Review Merck's stock information.
“MoonshotScore rates a US-listed stock 0 to 100 using five sector-relative pillars. Higher means stronger numbers across business quality, safety, valuation, growth and momentum. Eligible common stocks and ADRs only; funds, ETFs, warrants, units, SPACs, preferreds, and notes carry none. It is built for education and deeper due diligence, not financial advice.”
— Stock Expert AI published methodology (how MoonshotScore works)

Questions worth resolving before acting on the screen

What are the MoonshotScores of ABBV and MRK?

ABBV (AbbVie Inc.) has a MoonshotScore of 80 out of 100 and MRK (Merck & Co.) has 76 (scores dated 2026-10-26). ABBV scores 4 points higher. The MoonshotScore is a model rating, not a recommendation.

What is the latest recorded share price of ABBV and MRK?

ABBV last recorded $286.79 and MRK $140.61 (quotes dated 2026-10-26). These are the last provider quotes we hold, not streaming prices.

Which is larger by market capitalization, ABBV or MRK?

ABBV has a market capitalization of $506.8B and MRK $346.9B (quotes dated 2026-10-26). ABBV is about 1.5 times the size of MRK by market value.

Explore More Research

Stock Expert AI provides data and analysis tools for educational purposes. This is not financial advice. Past performance does not guarantee future results. Always consult a qualified financial advisor before making investment decisions. Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures.